Core Insights - The 2026 China Medical Equipment Conference and Exhibition successfully showcased innovations and advancements in the medical equipment sector, emphasizing collaboration and new directions in healthcare technology [1][61]. Group 1: Medtronic - Medtronic participated with the theme "Co-creating the Future of Medical Technology," displaying over a hundred products and solutions across cardiovascular, neuroscience, and surgical fields [3]. - The focus was on technologies related to stroke prevention and treatment, including products like the SpiderFX embolic protection device and the Pipeline™ flow-diverting stent, addressing various stages from risk prevention to disease intervention [6]. Group 2: Intuitive Surgical - Intuitive Surgical highlighted its 20 years of Da Vinci surgical robot presence in China, showcasing the Da Vinci Xi surgical system and Ion bronchial robot for lung cancer diagnosis [8]. - The company aims to enhance the ecosystem around surgical robotics, demonstrating a commitment to local development and application in various surgical fields [8]. Group 3: Precision Medicine - Precision Medicine introduced its "three-in-one" surgical robot platform, the first globally to integrate multi-port, single-port, and remote surgery capabilities [9][11]. - This platform aims to adapt to various surgical scenarios, enhancing the versatility of robotic surgery [13]. Group 4: MicroPort - MicroPort showcased its robotic products across multiple disciplines, including the Tumi™ laparoscopic surgical robot, emphasizing its application in complex and remote surgeries [14][16]. - The company has successfully completed remote surgeries over distances of 5,000 and 10,000 kilometers, demonstrating the feasibility of remote surgical collaboration [16]. Group 5: United Imaging - United Imaging presented high-end medical equipment and digital innovations, launching five core projects under the "2025 High-end Medical Equipment Promotion Application Project" [17]. - The showcased products included photon-counting CT and intelligent stereotactic radiotherapy systems, focusing on clinical application and industrialization [18]. Group 6: Mindray - Mindray exhibited its smart medical ecosystem, featuring the Qiyuan AI model and multi-scenario solutions across critical care, perioperative, ultrasound, and laboratory management [21][23]. - The company emphasized the integration of devices, IT, and AI to enhance medical efficiency and quality [23]. Group 7: KAILI Medical - KAILI Medical focused on ultrasound imaging, endoscopic diagnosis, cardiovascular intervention, and minimally invasive surgery, showcasing advanced products like the X11 portable ultrasound [24][26]. - The company engaged in academic exchanges to promote clinical applications and technological advancements [26]. Group 8: Rosenbot - Rosenbot highlighted its orthopedic surgical robots, providing comprehensive solutions for complex fracture treatments [27]. Group 9: SIZH Medical - SIZH Medical presented its Kando robot for thoracic and abdominal endoscopic surgery, demonstrating navigation and path planning capabilities for orthopedic applications [28][29]. Group 10: True Health - True Health introduced its percutaneous puncture navigation system, a pioneering NMPA-approved Class III innovative medical device [34][36]. Group 11: Noah Medical - Noah Medical showcased its Pulibai Chuan bronchial robot, designed for lung nodule and early lung cancer diagnosis, emphasizing navigation and imaging fusion capabilities [37][39]. Group 12: Sinoway - Sinoway focused on the localization of CT core components and specialized imaging devices, showcasing advancements in 512-slice CT and orthopedic CT [41]. - The company aims to enhance imaging technology applications in specific clinical scenarios [41]. Group 13: KOSMIND - KOSMIND presented the V1000 series magnifying endoscope system, focusing on multi-spectral imaging for early cancer diagnosis [43][45]. Group 14: Huaborn Neutron - Huaborn Neutron introduced its accelerator-based boron neutron capture therapy (BNCT) solution, marking a transition from research to clinical validation [47][49]. Group 15: Siemens Healthineers - Siemens Healthineers showcased innovations in high-end imaging and radiation therapy, emphasizing green technology and accessibility in healthcare [50][52]. - The company organized training on photon-counting CT applications, promoting the upgrade of imaging devices to clinical decision support platforms [54]. Group 16: GE Healthcare - GE Healthcare displayed over 40 products, with a focus on AI applications in imaging, enhancing service levels in grassroots healthcare [55][57]. - The company engaged in collaborations to support medical equipment management and talent development in the healthcare sector [57]. Group 17: Wandong Medical - Wandong Medical launched its "Smart Start" initiative, showcasing innovations in imaging diagnostics and intelligent applications [58][60]. - The company presented a range of imaging products, including a 4K ultra-high pixel DSA system and a quantum series mammography machine [60].

Core Viewpoint - The article highlights Siemens Healthineers' commitment to localizing its operations in China while introducing innovative medical technologies, aiming to transition from a product provider to a value partner in the healthcare sector [2][5][8]. Group 1: Localization and Innovation - Siemens Healthineers showcased multiple new products, including photon-counting CT devices, at the 8th China International Import Expo, emphasizing its strategy to bring global innovations to the Chinese market [2][3]. - The company has achieved over 80% localization in production, with more than 130 products manufactured locally, and plans to further enhance its local manufacturing capabilities [5][6]. - The introduction of the world's first photon-counting CT, NAEOTOM Alpha, represents a significant advancement, with plans for two new models to be produced in China by 2026 [5]. Group 2: Advanced Medical Solutions - The ARTIS icono ceiling Xpand system features a unique 0.5mm precision laser puncture navigation, significantly improving the accuracy of interventions for lung and liver cancers [3]. - The Biograph One PET/MR system allows simultaneous imaging of structural, functional, and molecular data, reducing scan times to 17 minutes, thus enhancing efficiency and accessibility [3]. - The SmART adaptive radiotherapy solution, designed for Chinese clinical needs, enables personalized treatment adjustments in real-time, improving patient outcomes [4]. Group 3: Strategic Collaborations and Future Plans - Siemens Healthineers has formed strategic partnerships, such as with Novartis, to explore integrated systems for molecular imaging and radioligand therapy, reinforcing its role as a value partner [7]. - The company is expanding its R&D and manufacturing base in Shenzhen, with an investment exceeding 1 billion RMB, aiming to triple the facility's capacity by 2027 [6]. - Siemens Healthineers plans to deepen its integration with clinical practices and enhance its sustainability efforts, focusing on creating a more open innovation ecosystem in China's healthcare sector [8].

2025 年 4 月 8 日， 春季 CMEF 展会 在上海如火如荼 ，思宇 MedTech 记者 探馆中， 注意到一个不寻常的现象： 在 西门子医疗的展台 上， 多款 创新设备几 乎覆盖了影像技术的所有关键临床节点 —— 从 110 微米分辨率的光子计数 CT NAEOTOM Alpha ，到 "自动驾驶" 的 C 臂 CT Ciartic Move 、极低辐射剂量的 PET/CT Biograph Vision Quadra 2.0 ，以及 配备创新超导 磁体 的 绿色磁共振系统 MAGNETOM Flow …… 这种高度聚合的创新组合 产品 ，即便在跨国企业中也属罕见。 为了一探究竟， 思宇 MedTech 采访 了 西门子医疗大中华区总裁、全球领导委员会成员 王皓 先生 ，想了解如此多款高度原创的产品是怎么做出来的。 王皓开门见山： 一句话，点破了核心问题：医疗设备的创新，不是单纯的技术指标、不是单一的产品，而是 形成协同创新的机制 ，从而不断诞生创新的产品。 # 医疗器械行业的创新逻辑：不是 "造出来"，而是"协作出来" 医疗器械不同于工业设备，它的核心价值不在于功能本身，而在于功能如何被临床 医生 ...